Your browser doesn't support javascript.
loading
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Li, Hanjie; van der Leun, Anne M; Yofe, Ido; Lubling, Yaniv; Gelbard-Solodkin, Dikla; van Akkooi, Alexander C J; van den Braber, Marlous; Rozeman, Elisa A; Haanen, John B A G; Blank, Christian U; Horlings, Hugo M; David, Eyal; Baran, Yael; Bercovich, Akhiad; Lifshitz, Aviezer; Schumacher, Ton N; Tanay, Amos; Amit, Ido.
  • Li H; Department of Immunology, Weizmann Institute, Rehovot, Israel.
  • van der Leun AM; Department of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Yofe I; Department of Immunology, Weizmann Institute, Rehovot, Israel.
  • Lubling Y; Department of Computer Science and Applied Mathematics and Department of Biological Regulation, Weizmann Institute, Rehovot, Israel.
  • Gelbard-Solodkin D; Department of Immunology, Weizmann Institute, Rehovot, Israel.
  • van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • van den Braber M; Department of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Rozeman EA; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Medical Oncology Department, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Haanen JBAG; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Medical Oncology Department, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Blank CU; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Medical Oncology Department, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Horlings HM; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • David E; Department of Immunology, Weizmann Institute, Rehovot, Israel.
  • Baran Y; Department of Computer Science and Applied Mathematics and Department of Biological Regulation, Weizmann Institute, Rehovot, Israel.
  • Bercovich A; Department of Computer Science and Applied Mathematics and Department of Biological Regulation, Weizmann Institute, Rehovot, Israel.
  • Lifshitz A; Department of Computer Science and Applied Mathematics and Department of Biological Regulation, Weizmann Institute, Rehovot, Israel.
  • Schumacher TN; Department of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: t.schumacher@nki.nl.
  • Tanay A; Department of Computer Science and Applied Mathematics and Department of Biological Regulation, Weizmann Institute, Rehovot, Israel. Electronic address: amos.tanay@weizmann.ac.il.
  • Amit I; Department of Immunology, Weizmann Institute, Rehovot, Israel. Electronic address: ido.amit@weizmann.ac.il.
Cell ; 176(4): 775-789.e18, 2019 02 07.
Article en En | MEDLINE | ID: mdl-30595452

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Melanoma Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Melanoma Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article